Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Neurology|March 1, 1985
Blind loop syndrome, vitamin E malabsorption, and spinocerebellar degenerationM F Brin, M R Fetell, P H Green, et al.
Neuroscience Letters|October 24, 1985
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moietyA J Bradbury, B Costall, A M Domeney, et al.
Annals of Neurology|November 1, 1989
Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritanceS B Bressman, D de Leon, M F Brin, et al.
Advances in Neurology|January 1, 1988
Inheritance of idiopathic torsion dystonia among Ashkenazi JewsS B Bressman, D de Leon, M F Brin, et al.
Neuropsychiatry, Neuropsychology, and Behavioral Neurology|July 26, 2000
A program for neuropsychological investigation of deep brain stimulation (PNIDBS) in movement disorder patients: development, feasibility, and preliminary dataC E Morrison, J C Borod, M F Brin, et al.
Archives of Neurology|December 1, 1996
Use of intrathecal baclofen in the treatment of patients with dystoniaB Ford, P Greene, E D Louis, et al.
Muscle & Nerve|July 1, 1991
Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changesD J Lange, M Rubin, P E Greene, et al.
Neurology|May 1, 1986
Electrophysiologic features of abetalipoproteinemia: functional consequences of vitamin E deficiencyM F Brin, T A Pedley, R E Lovelace, et al.
Neurology|February 20, 1999
Genetic analysis of three patients with an 18p- syndrome and dystoniaC Klein, C E Page, P LeWitt, et al.
Cephalalgia : an International Journal of Headache|July 22, 2010
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trialH C Diener, D W Dodick, S K Aurora, et al.
Pageof 11